Dr. Holger Warth
Born 1967 – German citizen
Chief Technology and Innovation Officer
Dr. Holger Warth is heading the Technology & Innovation department at medmix as Chief Technology and Innovation Officer since January 2023. He joined from Aliaxis where he served as Vice President Innovation & Product Development EMEA and as Chief Technology Officer of Hoya Vision Care. Earlier in his career, Holger Warth held several positions in the fields of Innovation and Research & Development, Marketing, Strategy and Business Consulting, among others for Bayer Material Science (now Covestro) based in Germany & Asia, SABIC based in the Netherlands and Saudi Arabia as well as Evonik based in Germany.
Dr. Holger Warth holds a PhD in Sustainable Polymers from the Albert-Ludwigs-University in Freiburg i. Br., Germany.